Radiopharm Theranostics Ltd (RADX) Assets (2024 - 2025)
Radiopharm Theranostics (RADX) posted quarterly Assets of $553858.6 for Q2 2025, up 16.67% year-over-year from $474737.2 in Q2 2024, and up 16.67% quarter-over-quarter from $474737.2 in Q2 2024.
Radiopharm Theranostics Ltd (RADX) Assets (2024 - 2025) Analysis & Trends
Radiopharm Theranostics (RADX) has reported Assets for 2 consecutive years, with $553858.6 the latest figure, recorded in Q2 2025.
- In Q2 2025, Assets rose 16.67% year-over-year to $553858.6; the TTM figure through Jun 2025 stood at $553858.6 (up 16.67% YoY), while the FY2025 annual figure was $86.5 million, up 20.05% from the prior year.
- Assets improved to $553858.6 in Q2 2025 per RADX's latest filing, from $474737.2 in the prior quarter.
- Across five years, Assets topped out at $553858.6 in Q2 2025 and bottomed at $474737.2 in Q2 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 553,858.65 |
| Jun 30, 2024 | 474,737.15 |